← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksUTIPrice Target
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

UTI logoUniversal Technical Institute, Inc. (UTI) Price Target Analysis

Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026

Current Price
$35.54
Market reference
Price Target
$49.00
+37.9% Upside
Target Range
$49.00 — $49.00
High conviction
Analyst Rating
Buy
11 analysts
Forward P/E44.5x
Trailing P/E31.5x
Forward PEG0.53
Implied Growth+4.3%
Median Target$49.00
Analyst Spread0.0%

Analysts see +37.9% upside to their consensus target of $49.00. The bullish rating consensus aligns with positive price target gap.

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$35.54
Consensus$49.00
High$49.00
Low$49.00
Bear Case
$49
+37.9%
Consensus
$49
+37.9%
Bull Case
$49
+37.9%

Analyst Ratings Distribution

Breakdown of 11 published analyst recommendations for UTI

9% hold / mixed conviction
+27
BearishBullish
Weighted analyst sentiment score based on 11 ratings
ConsensusBuy
Coverage11 Analysts
Net Score+27
Bull / Bear73% / 18%
Strong Buy00%
Buy873%
Hold19%
Sell218%
Strong Sell00%
Strong Buy
00%
Buy
873%
Hold
19%
Sell
218%
Strong Sell
00%
Recommendation Mix73% Buy · 9% Hold · 18% Sell
Buy (8)Hold (1)Sell (2)

UTI Price Target Analysis

Updated May 8, 2026

As of May 8, 2026, Universal Technical Institute, Inc. (UTI) has a Wall Street consensus price target of $49.00, based on estimates from 11 covering analysts. With the stock currently trading at $35.54, this represents a potential upside of +37.9%. The company has a market capitalization of $1.96B.

Analyst price targets range from a low of $49.00 to a high of $49.00, representing a 0% spread in expectations. The median target of $49.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Buy, with 8 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 2 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, UTI trades at a trailing P/E of 31.5x and forward P/E of 44.5x. The forward PEG ratio of 0.53 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +4.3% over the next year.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Consumer Defensive stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside+287.5%
Avg Forward P/E24.6x
Peers with Coverage8 / 10
CompanyMarket CapPriceTargetUpsideRatingFwd P/EAnalysts
LPSN logoLPSNLivePerson, Inc.$32M$2.68—————
PRDO logoPRDOPerdoceo Education Corporation$2.2B$34.44$30.00-12.9%Hold12.0x9
COCO logoCOCOThe Vita Coco Company, Inc.$3.9B$68.20$67.86-0.5%Buy41.1x14
GHC logoGHCGraham Holdings Company$4.9B$1127.53———17.0x—
STRA logoSTRAStrategic Education, Inc.$1.8B$79.09$87.00+10.0%Buy11.0x18
LINC logoLINCLincoln Educational Services Corporation$1.4B$44.10$38.80-12.0%Buy63.0x15
APEI logoAPEIAmerican Public Education, Inc.$992M$54.71$51.17-6.5%Hold22.5x19
LAUR logoLAURLaureate Education, Inc.$4.6B$32.17$39.00+21.2%Buy15.3x11
CHGG logoCHGGChegg, Inc.$143M$1.28$30.42+2276.6%Hold—22
COUR logoCOURCoursera, Inc.$1.1B$6.27$7.79+24.2%Buy15.2x17

Upside Potential Comparison

CHGG logoCHGG
+2276.6%
COUR logoCOUR
+24.2%
LAUR logoLAUR
+21.2%
STRA logoSTRA
+10.0%
COCO logoCOCO
-0.5%
APEI logoAPEI
-6.5%
LINC logoLINC
-12.0%
PRDO logoPRDO
-12.9%

See UTI's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is UTI Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare UTI vs WMT

Side-by-side business, growth, and profitability comparison vs Walmart Inc..

Start Comparison

UTI — Frequently Asked Questions

Quick answers to the most common questions about buying UTI stock.

What is the UTI stock price target for 2026?

The consensus Wall Street price target for UTI is $49, representing 37.9% upside from the current price of $35.54. With 11 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is UTI a buy, sell, or hold?

UTI has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 8 Buy/Strong Buy ratings. The consensus 12-month price target of $49 implies 37.9% upside from current levels.

Is UTI stock overvalued or undervalued?

At a forward P/E of 44.5029x, UTI trades at a premium valuation. The consensus price target of $49 (37.9% upside) suggests analysts still see growth justifying the multiple.

How high can UTI stock go?

The most bullish Wall Street analyst has a price target of $49 for UTI, while the most conservative target is $49. The consensus of $49 represents the median expectation. These targets typically reflect 12-month expectations.

How many analysts cover UTI stock?

UTI is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 1 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the UTI stock forecast?

The 12-month UTI stock forecast based on 11 Wall Street analysts shows a consensus price target of $49, with estimates ranging from $49 (bear case) to $49 (bull case). The median consensus rating is "Buy".

What is UTI's forward P/E ratio?

UTI trades at a forward P/E ratio of 44.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy UTI stock?

Wall Street analysts are very optimistic on UTI, with a "Buy" consensus rating and $49 price target (37.9% upside). 8 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do UTI price targets vary so much?

UTI analyst price targets range from $49 to $49, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $49 consensus represents the middle ground.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.